Federal Supply Schedule 36F79723D0037

Award Date 1/1/23
Last Date to Order 12/31/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Saptalis Pharmaceuticals, LLC, a for-profit limited liability company. The contract is a multiple-award vehicle under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance ending on March 31, 2025 and a ceiling value of $25,000.00. The contract aims to procure a range of pharmaceutical and...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), provides Supernus Pharmaceuticals, Inc. a five-year, $132.6 million ceiling to supply drugs, pharmaceuticals, and hematology-related products to VA medical facilities. As a multiple award schedule (MAS) contract under FSS-61-IB, it allows the VA to directly order pre-negotiated products from Supernus's catalog to efficiently meet the...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, aims to procure a variety of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,163,260.00 and a period of performance that extends through April 14, 2028. The prime contractor for this multiple-award FSS contract is Spectrum Pharmaceuticals, Inc., a for-profit organization and manufacturer of goods. The...
The Federal Supply Schedule (FSS) contract 36F79724D037E was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Day One Biopharmaceuticals, Inc. on June 3, 2024. The contract is a multiple award under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance through November 30, 2024. The purpose of this FSS contract is to provide the VISN 12 agency with interim...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Patriot Pharmaceuticals LLC, a for-profit manufacturer. The $23.18 million contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a period of performance from January 1, 2023 to December 31, 2027.

The contract was awarded as a multiple-award vehicle with no set-asides. It allows Patriot Pharmaceuticals to provide a range of pharmaceutical and drug products to VISN 12 and potentially other federal agencies through task orders or catalog pricing. The contract aims to procure a comprehensive portfolio of drugs and related medical supplies to support the healthcare needs of the veteran population served by VISN 12 and its affiliated medical facilities. Patriot Pharmaceuticals' experience as a manufacturer of pharmaceutical goods makes it well-positioned to fulfill the government's requirements under this contract.

Generated 7/17/25, 2:31 PM